Aegis Capital is bookrunning manager; H.C. Wainwright is lead manager
By Devika Patel
Knoxville, Tenn., March 11 – Heat Biologics, Inc. said it priced a $10.66 million public offering of stock with a $1.6 million greenshoe. The offering was announced Tuesday.
The company will sell 1.64 million common shares at $6.50 per share. The price per share reflects an 8.19% discount to the March 10 closing share price of $7.08.
Aegis Capital Corp. is the bookrunning manager.
Settlement is expected March 16.
Proceeds will be used for general corporate purposes.
The biopharmaceutical company is based in Durham, N.C.
| Issuer: | Heat Biologics, Inc.
|
| Issue: | Common stock
|
| Amount: | $10.66 million
|
| Greenshoe: | $1,599,000
|
| Shares: | 1.64 million
|
| Price: | $6.50
|
| Warrants: | No
|
| Bookrunner: | Aegis Capital Corp.
|
| Lead manager: | H.C. Wainwright & Co., LLC
|
| Announcement date: | March 10
|
| Pricing date: | March 11
|
| Settlement date: | March 16
|
| Stock symbol: | Nasdaq: HTBX
|
| Stock price: | $7.08 at close March 10
|
| Market capitalization: | $44.46 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
